silybin has been researched along with Cancer of Nasopharynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amir-Tidadini, ZC; Bourouba, M; Chettibi, F; Djennaoui, D; Merghoub, T; Ouahioune, W; Sellam, LS; Touil-Boukoffa, C; Yahi-Ait Mesbah, N; Zappasodi, R | 1 |
| Mahendran, R; Pook, SH; Toh, CK | 1 |
2 other study(ies) available for silybin and Cancer of Nasopharynx
| Article | Year |
|---|---|
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; B7-H1 Antigen; Biopsy; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Down-Regulation; Drug Discovery; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactate Dehydrogenase 5; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxidative Phosphorylation; Signal Transduction; Silybin | 2020 |
Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumor; Down-Regulation; Drug Antagonism; Drug Screening Assays, Antitumor; Enzyme Activation; Guanidines; Humans; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Signal Transduction; Silybin; Silymarin; Sulfhydryl Compounds; Up-Regulation | 2006 |